AGP Picks
View all

Yemen Health Report
Provided by AGP

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Jul. 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
Jul. 27, 2026

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Indeterminate GlobeNewswire
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
Jul. 27, 2026

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

Indeterminate GlobeNewswire
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
Jul. 27, 2026

Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.

Indeterminate GlobeNewswire
Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
Jul. 27, 2026

Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026

Indeterminate GlobeNewswire
CorVel Corporation to Host Live Earnings Release Webcast
Jul. 27, 2026

CorVel Corporation to Host Live Earnings Release Webcast

Indeterminate GlobeNewswire
The Ensign Group Reports Second Quarter 2026 Results
Jul. 27, 2026

The Ensign Group Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
Legend Biotech Announces CEO Transition
Jul. 27, 2026

Legend Biotech Announces CEO Transition

Indeterminate GlobeNewswire
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
Jul. 27, 2026

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Indeterminate GlobeNewswire
ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division
Jul. 27, 2026

ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division

Indeterminate GlobeNewswire
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
Jul. 27, 2026

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.